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Abstract: The study was undertaken to determine the prevalence and treatment of antibiotic resistant mastitis in 
dairy cows. The predominant resistant causative pathogen was Escherichia coli (50.64 %) followed by S. aureus (44.25 %) 
and Methicillin resistant Staphylococcal aureus (5.11%).These isolates were found sensitive to gentamicin,  
enrofloxcain, amoxicillin+sulbactam, ceftriaxone and resistant to amoxicillin, oxytetracycline, penicillin G and  
oxacillin. In all the treatment groups of E. coli, S. aureus and MRSA mastitis, the post treatment pH, SCC was  
significantly (P < 0.01) decreased when compared to pre treatment pH, SCC values and the post treatment electrical 
conductivity was significantly (P < 0.01) increased when compared to pre treatment electrical conductivity value. In 
E. coli mastitis, treated with amoxicillin+sulbactam, ceftriaxone, enrofloxacin and gentamicin showed  74.1%, 
67.75 %, 76.67 % and 64.52 % clinical recovery and in S. aureus mastitis, showed 65.25 %, 65.25 %, 72.43 % and 
68.98 % clinical recovery. In MRSA mastitis, enrofloxacin was found to be highly effective in comparison to  
amoxicillin+sulbcactam. 
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INTRODUCTION 
Mastitis is considered as most important disease affecting 
the productive performance of cattle world-side  
contributing to the economic losses (Kumar et al., 
2010). In the control of mastitis, the improper use of 
antimicrobial agents on dairy farm animals is a major 
concern as it leads to the emergence of resistant zoonotic 
bacterial pathogens (Piddock, 1996). The emergence of 
antibiotic-resistance in S. aureus from mastitic dairy 
animals has been shown in recent years. Beta–lactam 
antibiotics are frequently used in mastitis therapy and 
the resistance is due to the production of  
beta-lactamases and low–affinity penicillin-binding 
protein, PBP2A (Olsen et al., 2006). 
Acquired antimicrobial resistance in bacteria is an  
increasing threat in human as well as in veterinary 
medicine. Among the various antibiotic-resistant 
strains the Methicillin-resistant  S. aureus (MRSA) is a 
serious cause because of its public health significance. 
All MRSA were resistant to members of the penicillin 
family, such as ampicillin, oxacillin and penicillin. In 
India, high prevalence of MRSA (13.1 %) and the  
isolates were resistant to streptomycin, oxytetracycline, 
gentamicin and chloramphenicol, pristinomycin and 
ciprofloxacin (Kumar et al., 2011). As on date  
β-lactamase resistant penicillins such as methicillin 
and oxacillin are not used in dairy cows except for 
cloxacillin in some of the products used for  
intramammary administration (Turutoglu et al., 2006). 
Comprehensive information on the prevalence of  
antimicrobial resistance in bovine mastitis pathogens 
in milk and their management is lacking in India.  
Enrofloaxacin was found to be most effective against 
MRSA (Kenar et al., 2012). Keeping this in view, the 
present study, an attempt has been made to find out the 
treatment of resistant mastitis in dairy cows. 
MATERIALS AND METHODS 
Sampling and bacterial culture: 401 milk samples 
from acute mastitis cases from Large Animal Clinic 
Medicine Unit of Madras Veterinary College Teaching 
Hospital and six dairy farms in Coimbatore district 
were collected, transported, cultured. The Escherichia 
coli and Staphylococci were isolated as per the  
guidelines of National Mastitis Council (NMC). The 
S. aureus isolates were also characterized by their 
growth on blood agar and mannitol salt agar, the     
positive results for catalase and coagulase while the   
E. coli isolates were identified on eosin methylene blue 
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agar, a negative oxidase test. Based on incidence of 
common causative pathogen and sensitivity tests, iso-
lates were categorized as resistant i.e exhibiting in vi-
tro resistance to 1 or 2 antimicrobials and multidrug-
resistant i.e  
exhibiting in vitro resistance to 3 or more antimicrobials. 
Cows with resistant mastitis were grouped as follows, 
Group I E. coli (n=119), Group II Staphylococcus 
aureus (n=104) and Group III Methicillin resistant             
S. aureus (n=12). 
Antibiotic sensitivity test: Antimicrobial susceptibility 
testing was carried out at equivalent to 0.5 McFarland 
turbidity standard by agar disc diffusion method on 
Mueller-Hinton agar plates following the guidelines of 
CLSI (2008).  All the bacteria isolated were tested in 
vitro for their sensitivity to 8 antibiotics viz.,  
Enrofloxacin, Amoxicillin+sulbactam, Amoxicillin, 
Gentamicin, Ceftriaxone, Oxytetracycline, Penicillin G 
and Oxacillin that are commonly used in veterinary 
practice. 
PCR for identification of the mastitis causing bacteria: 
The isolates were confirmed to be E. coli and S. aureus 
by targeting the specific gene 16s-23s r RNA and gap 
gene as described by Riffon et al., (2001) and Yugueros 
et al., (2001). The Staphylococci isolates were  
confirmed to be MRSA by amplifying the MRSA  
specific genes mecA and blaZ as described by Lee, 
(2003) and Martineau et al. (2000), respectively. 
Clinical signs: The cows with acute clinical mastitis 
exhibiting clinical signs such as inappetance, anorexia, 
pyrexia, reduced rumen motility, swelling of udder, hot 
and painful udder. Milk colour changes include dirty 
white, yellowish colour, flakes, serous/ watery and 
blood mixed.  Clinical examination was carried out as 
described by Boddie, (2000). 
pH, electrical conductivity and somatic cell count 
(SCC): The collected milk samples were further  
subjected to pH (pH strips), Electrical conductivity 
(DRAMINSKI mastitis detector) and somatic cell 
count (De Laval somatic cell counter). The SCC value 
> 5,00,000 cells / ml of milk with clinical signs were 
taken as criteria to declare the animal as clinically 
mastitic. The results were statistically analyzed,  
utilizing SPSS – Version 14 statistical software package. 
Treatment: Based on culture, antibiotic sensitivity 
test, cows were allotted the following four treatment 
trial. 
1. Gentamicin @ 4mg / kg body weight IM once daily 
for 7 days in E. coli (n=31) group and S. aureus (n=29) 
group as well as 100 mg per quarter intramammary 
infusion once daily for 7 days in S. aureus group. 
2. Ceftriaxone @ 5 mg / kg body weight IM once daily 
for 7 days in E. coli (n=31) group and S. aureus (n=23) 
group as well as Ceftriaxone 250 mg per quarter  
intramammary infusion once daily for 7 days in          
S. aureus group. 
3. Enrofloxacin @ 5 mg / kg body weight IM once 
daily for 7 days in E. coli (n=30) group,  S. aureus 
(n=29) group and MRSA (n=6) group as well as 100 
mg per quarter intramammary infusion once daily for 7 
days in S. aureus and Methicillin resistant S. aureus 
(MRSA) group. 
4. Amoxycillin + Sulbactam @ 10 mg / kg body 
weight IM twice daily for 7 days in E. coli (n=27) 
group, S. aureus (n=23) group and MRSA (n=6) group 
as well as 300 mg per quarter intramammary infusion 
once daily for 7 days in  S. aureus and Methicillin resistant  
S. aureus (MRSA) group. 
Depending on the severity, cows in all groups were 
treated with non-steroidal anti-inflammatory drug 
meloxicam IV @ 0.5 mg/kg body wt daily for 1-5 days 
and chlorpheniramine maleate @ 0.5 mg /kg body wt 
IM daily for 5 days. In E. coli group Normal Saline 
was administered @10 ml/kg body weight IV daily for 
1-5 days depending on the severity. Post treatment 
assessment was carried out after 7 days, based on milk 
pH, electrical conductivity, somatic cell count and 
clinical improvement. 
RESULTS  
Antibiotic resistant mastitis was detected in 235 out of 
401 cows accounting to 56.1 %. The predominant resistant 
causative pathogen was E. coli (50.64 %) followed by 
S. aureus     (44.25 %) and MRSA (5.11 %). 
Antibiotic sensitivity test: E. coli showed more sensitivity 
to enrofloxacin (79 %) followed by amoxicillin and sulbactam 
(74 %), gentamicin (73.1 %) and ceftriaxone (69 %). The 
isolates had highest resistance to penicillin (63 %) followed 
by amoxicillin (52.1 %), oxytetracycline (47.9 %) and  
methicillin (45.4 %). Most of the E. coli isolates (86.55 %) 
were found to be resistant i.e resistance to 1 or 2 of 
antimicrobials and few E. coli isolates (13.45 %) were 
found to be multi-drug resistant i.e resistance to 3 or 
more of antimicrobials. 
S. aureus isolates were most sensitive to enrofloxacin (79.8 
%) followed by gentamicin (71.2 %), amoxicillin and 
sulbactam (69.2 %) and ceftriaxone (69.2 %). The isolates 
showed highest resistance to penicillin (63.5 %) followed 
by amoxicillin (61.5 %), oxytetracycline (49 %) and methicillin 
(52.9 %). Most of the S. aureus isolates (80.77 %) were 
found to be resistant i.e reistance to 1 or 2 of antimicrobials 
and few S. aureus isolates (19.23 %) were found to be 
multi-drug resistant i.e resistance to 3 or more of  
antimicrobials. 
MRSA showed maximum sensitivity to enrofloxacin (75 %), 
amoxicillin and sulbactam (75 %) followed by gentamicin 
(66.7 %) and ceftriaxone (58.3 %). The isolates showed 
highest resistance to methicillin (100 %), amoxicillin   
(91.7 %), followed by penicillin (83.3 %) and oxytetracy-
cline (41.7 %). Few MRSA isolates (8.33 %) were 
found to be resistant i.e resistance to 1 or 2 of antim-
icrobials and most of the MRSA isolates (91.67 %) 
were found to be multi-drug resistant i.e resistance to 3 
or more of antimicrobials. 
PCR for identification of the mastitis causing bacteria : 
Out of 235 milk samples, the specific target gene 16s-23s 
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r RNA (E. coli) could be amplified from 119 isolates 
with a %age of positivity as 50.64 (119/235), gap gene 
(S. aureus) could be amplified from 104 isolates  with 
a %age of positivity as 44.25 (104/235). Screening for 
the specific target gene for both mecA (MRSA) and 
blaZ (MRSA) resulted in positivity in 12 samples with 
a %age of positivity as 10.34 (12/116) among the S. 
aureus isolates. 
pH, electrical conductivity and somatic cell count 
(SCC): The post treatment mean ± S.E values of milk 
pH, Electrical conductivity and SCC in E. coli,           
S. aureus and MRSA isolates are as given in tables 1- 3.  
In E. coli, S. aureus and MRSA groups, a highly  
significant (P < 0.01) decrease in post treatment milk 
pH values was observed in all treatment groups when 
compared to pre treatment group. In E. coli and          
S. aureus groups, post treatment pH value (Tables 1 
and 2) of treatment groups showed lowering trend  
towards control group. However, In MRSA group, the 
post treatment pH value (Table 3) of enrofloxacin 
group was comparable to the control value and                   
amoxicillin + sulbactam group was slightly above the   
control value. 
In E. coli, S. aureus and MRSA groups, a highly significant 
(P < 0.01) increase in post treatment milk electrical 
conductivity values (Tables 1, 2 and 3) was observed 
in all treatment groups when compared to pre treatment 
values. However, in E. coli, S. aureus groups, there 
was no significant difference between different treatment 
groups in post treatment values and post treatment 
electrical conductivity value of treatment groups 
showed increasing trend towards control group.  
In MRSA group, post treatment electrical conductivity 
value of enrofloxacin group showed increasing trend 
when compared to control group. Even though significant 
increase in post treatment electrical conductivity was 
observed in amoxicillin+sulbactam group, it did not 
reach the values towards control group. 
In E. coli, S. aureus and MRSA groups, a highly significant 
(P < 0.01) decrease in post treatment milk SCC values 
(Tables 1, 2 and 3) was observed in all treatment 
groups when compared to pre treatment values. However, 
in E. coli, S. aureus groups, there was no significant 
difference between different treatment groups in post 
treatment value and post treatment SCC value of treatment 
groups showed lowering trend towards control group.  
In MRSA group, post treatment SCC value of  
enrofloxacin group showed lowering trend towards 
control group. Whereas post treatment SCC value of 
amoxicillin+sulbactam group was slightly above the 
control value.  
Clinical signs: In E. coli group, 74.1 %, 67.75 %, 76.67 
% and 64.52 % of cases treated with amoxicillin+sulbactam, cef-
triaxone, enrofloxacin and gentamicin respectively 
showed normal milk colour. 
In S. aureus group, 65.25 %, 65.25 %, 72.43 % and 
68.98 % of cases treated with amoxicillin+sulbactam, 
ceftriaxone, enrofloxacin and gentamicin respectively 
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showed normal milk colour. 
In MRSA group, 50 %, and 50 % of cases treated with 
amoxicillin+sulbactam and enrofloxacin respectively 
showed normal milk colour. 
DISCUSSION 
Mastitis is the most common cause for antibiotic use in 
dairy herds. However, improper use of antibiotics creates 
problems such as the emergence of bacterial resistance 
to antibiotics. The present study has demonstrated the 
existence of alarming levels of resistance of E .coli,    
S. aureus and MRSA to commonly used antimicrobial 
agents in the study farms and the results are in accordance 
with reports from earlier studies in other countries. 
Edward et al., (2002) suggesting a possible development 
of resistance from prolonged and indiscriminate usage 
of some antimicrobials. Systemic application of an in 
vitro antibiotic susceptibility test prior to the use of 
antibiotics in the treatment of intra-mammary infections 
will prevent the antibiotic resistance. 
Based on the antibiotic susceptibility test E. coli, S. aureus 
and MRSA showed maximum sensitivity to enrofloxacin, 
amoxicillin + sulbactam followed by gentamicin and ceftri-
axone. These susceptible antibiotic drugs will be used 
as the effective drugs against E. coli, S. aureus and 
MRSA resistant isolates.  
In the present study, in all the treatment groups of      
E. coli and S. aureus mastitis, the post treatment pH, 
SCC was significantly decreased when compared to 
pre treatment pH, SCC values indicated that the treat-
ment was effective in controlling the inflammation. 
The post treatment electrical conductivity was        
significantly increased when compared to pre        
treatment electrical conductivity value.  
In the present study, cows affected with E. coli and S. 
aureus mastitis treated with amoxycillin+sulbactam, 
ceftriaxone, enrofloxacin and gentamicin showed uniform 
improvement in clinical mastitis. In E. coli mastitis, 
treated with amoxicillin+sulbactam, ceftriaxone, enrofloxacin 
and gentamicin showed 74.1 %, 67.75 %, 76.67 % and 
64.52 % clinical recovery and in S. aureus mastitis, 
showed 65.25 %, 65.25 %, 72.43 % and 68.98 % clinical 
recovery and this might be due to isolates were found 
to be resistant i.e. resistance to 1 or 2 of antimicrobials. 
The present observation was in agreement with 
Karthikeyan, (2003) who reported that the most sensitive 
antimicrobial agent against gram negative pathogens 
(E. coli ) was found to be enrofloxacin (100 %) followed 
by ciprofloxacin and gentamicin and  sensitive antimicrobial 
agent against gram positive pathogens were found to 
be gentamicin followed by ciprofloxacin and  
enrofloxacin.  
Evira (2009) recommended fluroquinolone as the first 
antibiotic of choice for E. coli mastitis because of 
pharmacokinetic and pharmacodynamic properties.  
Highest clinical recovery rate was recorded in the bovine 
mastitis treated with gentamicin (84.21 %) followed by 
enrofloxacin (80.77 %) within 3.32 and 3.46 days Ta
bl
e 
2.
 
Co
m
pa
ris
o
n
 
o
f p
o
st
 
tr
ea
tm
en
t v
al
u
es
 
o
f p
H
,
 
EC
 
an
d 
SC
C 
in
 
S.
 
a
u
re
u
s 
m
as
tit
is 
am
o
n
g 
di
ffe
re
n
t g
ro
u
ps
 
o
f a
n
tib
io
tic
s.
 
S.
 
N
.
 
Pa
ra
m
et
er
s 
C
o
n
tr
o
l 
A
m
o
x
ic
ill
in
 
+
 
su
lb
a
ct
a
m
 
(n
=
23
) 
C
ef
tr
ia
x
o
n
e 
(n
=
23
) 
En
ro
flo
x
a
ci
n
 
(n
=
29
) 
G
en
ta
m
ic
in
 
(n
=
29
) 
F 
-
 
v
a
lu
e 
 
 
 
 
 
Pr
e 
Po
st
 
Pr
e 
Po
st
 
Pr
e 
Po
st
 
Pr
e 
Po
st
 
1 
pH
 
6.
45
 
a  
±
 
0.
05
 
7.
69
 
b  
±
0.
10
 
6.
50
a  
±
0.
06
 
7.
76
 
b  
±
0.
13
 
6.
56
a  
±
0.
08
 
7.
63
 
b  
±
0.
04
 
6.
53
a  
±
0.
08
 
7.
51
 
b  
±
0.
09
 
6.
53
a  
±
0.
07
 
42
.
64
0*
*
 
2 
El
ec
tr
ic
al
 
co
n
du
ct
iv
ity
 
(U
n
its
) 
35
6.
00
 
c ±
 
6.
42
 
23
5.
21
 
a 
 
 
 
±
3.
71
 
32
2.
41
b  
±
8.
95
 
23
4.
78
 
a 
 
 
 
±
3.
96
 
31
9.
56
 
b  
±
9.
14
 
24
1.
72
 
a 
 
 
 
±
3.
94
 
32
2.
06
 
b  
±
8.
64
 
24
1.
37
 
a 
 
 
 
±
4.
31
 
29
1.
73
 
b  
±
11
.
06
 
41
.
18
4*
*
 
3 
SC
C 
x
 
10
3  
60
.
95
 
a  
 
±
 
8.
52
 
23
16
.
21
c 
 
 
 
 
±
14
6.
72
 
20
3.
17
 
b  
±
24
.
33
 
23
78
.
39
 
c 
 
 
±
22
2.
62
 
22
3.
44
 
b  
±
29
.
60
 
23
46
.
48
 
c 
 
 
±
15
8.
6 
21
2.
60
 
b  
±
32
.
44
 
22
98
.
20
c 
±
12
6.
41
 
21
8.
27
 
b  
±
28
.
7 
97
.
12
7*
*
 
M
ea
n
 
be
ar
in
g 
th
e 
sa
m
e 
su
pe
rs
cr
ip
t i
n
 
th
e 
sa
m
e 
ro
w
 
do
 
n
o
t d
iff
er
 
sig
n
ifi
ca
n
tly
; *
*
 
 
H
ig
hl
y 
sig
n
ifi
ca
n
t (
P<
0.
01
) 
D. Chandrasekaran et al. / J. Appl. & Nat. Sci. 6 (2): 786 - 791 (2014) 
790  
(average) respectively (Tufani et al., 2012). 
Ceftriaxone is a third generation cephalosporin and has 
remarkable activity against Enterobacteriaceae 
(Prescott and Baggot, 1994) and Staphylococcus Spp. 
(Sumathi et al., 2008). 
In MRSA mastitis, treated with amoxicillin+sulbactam 
and enrofloxacin showed 50 % clinical recovery and 
lower clinical recovery compared to E. coli and          
S. aureus mastitis might be due to multi-drug resistant 
i.e resistance to 3 or more of antimicrobials. 
Based on the post treatment pH, EC and SCC values, 
enrofloaxacin was found most effective antibiotic 
against MRSA (Kenar et al., 2012). This might be due 
to immunomodulatory (Hoeben et al., 1997), concentration 
dependent and post antibiotic effect. Hui et al. (2013) 
also reported that a good bactericidal activity in vitro 
was achieved for AMX/SUL (4:1) combination against 
common mastitis pathogens in cows. In the present 
study, Amoxicillin+ sulbactam was sensitive in vitro 
(6 out of 6 cases) but it had a poor efficacy in vivo (3 
out of 6 cases). The lower efficacy of amoxicillin  
+ sulbactam noticed in the current study might be due 
to development of resistance by bacterial strains which 
was confirmed by PCR by targeting specific gene 
mecA and blaZ. Loeffler and Lloyd, (2010) opined that 
detection of mecA and blaZ gene by PCR was gold 
standard test for confirmation of methicillin resistance. 
Local clinical signs, such as swelling, pain and firmness 
of the inflamed mammary quarters, were less severe in 
the treated cows (Hoeben et al., 2000). 
Conclusion 
It was concluded that systemic application of an in 
vitro antibiotic susceptibility test prior to the use of 
antibiotics in the treatment of intra-mammary infections 
will prevent the antibiotic resistance. Cows affected 
with E. coli and S. aureus mastitis treated with  
amoxycillin+sulbactam, ceftriaxone, enrofloxacin and 
gentamicin showed uniform improvement. In MRSA 
mastitis, treated with amoxicillin+sulbactam and  
enrofloxacin showed 50 % clinical recovery. 
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